QURE | uniQure N.V. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	16.81 - 18.12
52 Week Range	3.73 - 18.12
Beta	0.89
Implied Volatility	65.04%
IV Rank	26.04%
Day's Volume	427,107
Average Volume	2,060,761
Shares Outstanding	48,743,100
Market Cap	845,692,785
Sector	Healthcare
Industry	Biotechnology
IPO Date	2014-02-05

Valuation
Profitability
Growth
Health
P/E Ratio	-3.51
Forward P/E Ratio	N/A
EPS	-4.95
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	480
Country	Netherlands
Website	QURE

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

QURE's peers: ADVM, MGTX, RCKT, RYTM, SLDB, TERN, AMLX, ABOS, INZY, XFOR, PCVX, LRMR, SNDX, MRUS, STRO, KNSA, DAWN, GPCR, KRTX, PHAT, RGNX, REPL, RNA, PTGX, VCYT

*Chart delayed

Analyzing fundamentals for QURE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is weak. For more detailed analysis please see QURE Fundamentals page.

Watching at QURE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on QURE Technicals page.